12/30/2025HUTCHMED's Fanregratinib NDA Granted Priority Review in China

12/30/2025Recbio's Files NDA for Shingles Vaccine REC610 China

12/30/2025China Rejects Tianmai Biotech's Oral Insulin Capsule ORMD-0801

12/30/2025AstraZeneca and Daiichi Sankyo Secures Chinese Approval of Enhertu fo...

12/30/2025Innovent's Ipilimumab IBI310 for Neoadjuvant Therapy approved in China

12/30/2025China Approves AstraZeneca and Ionis' Wainua for ATTRv-PN

12/30/2025Simcere Registers Phase 1 MRCT for EGFR/c-Met Bispecific ADC SIM0610 i...

12/30/2025Innovent Submits Clinical Trial Application for Novel Bispecific Dual-...

12/27/2025Telix Advances Regulatory Efforts with Positive China Phase 3 Data

12/27/2025China Approves Novo Nordisk's Sogroya for Pediatric Growth Hormone Def...

12/27/2025Zai Lab's COBENFY Approve in China for Schizophrenia

12/27/2025GRIT's Next-Generation Gene-Edited TIL GT307 Receives FDA IND Approval

12/27/2025NMPA Approves Amgen/UCB's Evenity for Postmenopausal Osteoporosis

12/27/2025China Approves GSK's Nucala for Maintenance Treatment of Eosinophilic ...

12/23/2025CSPC Announces China Approval for Daratumumab Injection

12/23/2025Qilu Launches Phase 1 Trial of FIC CD3/CD20/CD79b Triple Antibody QLS2...

12/23/2025T-MAXIMUM Secures FDA Approval to Advance Off-the-Shelf CAR-T Therapy

12/23/2025China Approves First Global CSF-1R Inhibitor Pimicotinib for Rare Join...

12/22/2025Alphamab's IND for PD-L1/VEGFR2 Bispecific ADC JSKN027 Accepted in Chi...

12/22/2025Epigenic Wins FDA IND Clearance for Novel Epigenetic Therapy Targeting...

12/18/2025Rona Advances Dual-Targeting siRNA RN5681 Into Clinical Development

12/18/2025HUTCHMED Initiates Global Clinical Development of FIC ATTC Candidate H...

12/18/2025China Grants First Global Approval to Cytokinetics' Cardiomyopathy Dru...

12/18/2025Atom Thera Advances Anti-Inflammatory Pipeline With FDA Clearance for ...

12/18/2025Sanofi's Aficamten Wins China Approval for Obstructive Hypertrophic Ca...

12/16/2025China Approves Genzyme's Fenthosilan Sodium Injection

12/16/2025InnoCare's Orelabrutinib Hits Primary Endpoint in Phase 2b Lupus Trial...

12/15/2025Qilu Advances GSPT1 Degrader ADC Program, PCT Patent Reveals

12/15/2025AusperBio Reports Promising Phase 2a Results for AHB-137 in Chronic He...

12/15/2025Qilu Wins Approval for China's First Fully Human Anti-EGFR Antibody

Page:1/21 Total number of articles:616: [First][<<] [1] [2] [3] [4] [5] [>>] [End]